| Title | Author(s) | Year | View Count |
 | The T393C polymorphism of GNAS1 as a predictor for chemotherapy sensitivity and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus platinum | Xie, FJ; Zhao, P; Kou, JY; Hong, W; Fu, L; Hu, L; Hong, D; Su, D; Gao, Y; Zhang, YP | 2012 | 62 |
| Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy | Wu, VWC; Kwong, DLW; Sham, JST | 2004 | 82 |
| A targeted disruption of the murine Brca1 gene causes γ-irradiation hypersensitivity and genetic instability | Shen, SX; Weaver, Z; Xu, X; Li, C; Weinstein, M; Chen, L; Guan, XY; Ried, T; Deng, CX | 1998 | 70 |
 | Targeted inhibition of the EGFR pathways enhances Zn-BC-AM PDT-induced apoptosis in well-differentiated nasopharyngeal carcinoma cells | Koon, HK; Chan, PS; Wong, RNS; Wu, ZG; Lung, ML; Chang, CK; Mak, NK | 2009 | 214 |
| Telomere capture stabilizes chromosome breakage | Meltzer, PS; Guan, XY; Trent, JM | 1993 | 61 |
 | Ten years experience with radioactive gold grain implant for nasopharyngeal carcinoma | Kwong, DLW | 1999 | 49 |
| The application of the tumor control probability model of nasopharyngeal carcinoma in three dimensional conformal treatment planevaluation | Wu, Po-man.; 胡寶文 | 2000 | 396 |
| The functional roles of the polymorphisms of a secretary candiate tumor suppressor, serum amyloid A1 (SAA1), in nasopharyngeal carcinoma(NPC) | Yeung, Man-chung; 楊敏聰 | 2011 | 186 |
| THSD1: a candidate tumor suppressor attenuates angiogenesis, migratory and invasive potential of endothelial cells | Ko, JMY; Cheung, AKL; Lung, ML | 2011 | 74 |
| THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma | Lung, HL; Bangarusamy, DK; Xie, D; Cheung, AKL; Cheng, Y; Kumaran, MK; Miller, L; Liu, ETB; Guan, XY; Sham, JS; Fang, Y; Li, L; Wang, N; Protopopov, AI; Zabarovsky, ER; Sai, WT; Stanbridge, EJ; Lung, ML | 2005 | 256 |
| Thymomatous myasthenia gravis | Liu, HHW; Tsang, JWH; Pang, SYY; Ho, SL; Cheung, RTF; Chu, ACY; Tse, MMY; Mak, W; Ho, WL; Chan, KH | 2010 | 135 |
| Thymomatous myasthenia gravis among Hong Kong Chinese | Chan, KH; Tsang, JWH; Mak, W; Liu, HHW; Ho, SL; Cheung, RTF | 2010 | 134 |
| The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma | Kwong, DLW; Nicholls, J; Wei, WI; Chua, DTT; Sham, JST; Yuen, PW; Cheng, ACK; Wan, KY; Kwong, PWK; Choy, DTK | 1999 | 115 |
| Time factor in radiotherapy for nasopharyngeal carcinoma | Kwong, DLW | 1996 | 63 |
| Tissue distribution of Epstein-Barr virus genotypes | Chen, HL; Lung, ML; Chan, KH; Griffin, BE; Ng, MH | 1996 | 65 |
| Tissue microarray analysis of cyclin D1 gene overexpression in the multistage carcinogenesis of nasopharyngeal carcinoma | Song, X; Zhao, XR; Wang, Y; Zhou, JH; Guan, XY; Cao, Y | 2002 | 58 |
| Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctiva | Chan, RWY; Kang, SSR; Yen, HL; Li, ACL; Tang, LLS; Yu, WCL; Yuen, KM; Chan, IWW; Wong, DDY; Lai, WW; Kwong, DLW; Sihoe, ADL; Poon, LLM; Guan, Y; Nicholls, JM; Peiris, JSM; Chan, MCW | 2011 | 141 |
| To delineate biological tumour volume of nasopharyngeal carcinoma frompositron emission tomography image | Wong, Ka-wai; 黃嘉威 | 2011 | 252 |
| To treat or not to treat? An oncologist's perspective on suspension of radiation treatment due to patient position deviations | Kwong, DLW | 2008 | 108 |
| Tolerability of topotecan in refractory metastatic neuroblastoma after autologous haematopoietic stem cell transplantation (auto-HSCT) | Chan, GCF; Kwong, DLW; Chan, KL; Ha, SY; Chiu, DCK; Cheng, W; Tam, PKH; Lau, YL | 1998 | 95 |
|
